semaglutide romania ESC 2025: Novo Nordisk's Wegovy superior to Zepbound in reducing CV events Semaglutide shortage ends as FDA

MITO 2: Las grasas saturadas causan enfermedades cardacas VERDAD: La evidencia es contradictoria

New Results Medical Weight Loss is a non-surgical, medical weight loss clinic that provides individualized programs to help patients lose weight and make lifestyle changes that will have lasting RESULTS.

Theres no strong proof that injections provide significantly greater weight loss for most people

Researchers have found some evidence to suggest that glutathione supplementation could benefit some people, but it may cause adverse side effects.

A temporary Medicare GLP-1 Bridge program now covers Wegovy, Zepbound, and Foundayo at $50/month through December 31, 2027, but retatrutide isn't expected to be approved until late 2027 at the earliest, meaning it will likely miss this window

Continuous education empowers us to mitigate risks effectively